| Primary |
| Product Used For Unknown Indication |
49.7% |
| Diabetes Mellitus |
17.3% |
| Type 2 Diabetes Mellitus |
15.7% |
| Depression |
2.6% |
| Rheumatoid Arthritis |
2.1% |
| Hypertension |
1.6% |
| Blood Pressure Fluctuation |
1.0% |
| Hyperglycaemia |
1.0% |
| Insulin Resistance |
1.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.0% |
| Pain In Extremity |
1.0% |
| Venous Occlusion |
1.0% |
| Wound Infection |
1.0% |
| Acromegaly |
0.5% |
| Analgesic Therapy |
0.5% |
| Blood Cholesterol Abnormal |
0.5% |
| Blood Glucose Increased |
0.5% |
| Cardiovascular Disorder |
0.5% |
| Diarrhoea |
0.5% |
| Essential Hypertension |
0.5% |
|
| Hypoglycaemia |
13.9% |
| Dehydration |
8.3% |
| Alcoholism |
5.6% |
| Blood Pressure Increased |
5.6% |
| Confusional State |
5.6% |
| Diabetes Mellitus Inadequate Control |
5.6% |
| Dialysis |
5.6% |
| Drug Interaction |
5.6% |
| Lactic Acidosis |
5.6% |
| Metabolic Acidosis |
5.6% |
| Renal Failure |
5.6% |
| Renal Failure Acute |
5.6% |
| Abdominal Pain |
2.8% |
| Accidental Overdose |
2.8% |
| Anaemia |
2.8% |
| Anuria |
2.8% |
| Blood Glucose Increased |
2.8% |
| Blood Lactate Dehydrogenase Increased |
2.8% |
| Blood Potassium Increased |
2.8% |
| Cardiac Failure |
2.8% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
40.5% |
| Product Used For Unknown Indication |
14.4% |
| Diabetes Mellitus |
11.1% |
| Hypertension |
10.5% |
| Cardiac Disorder |
2.6% |
| Abnormal Sensation In Eye |
2.0% |
| Bipolar Disorder |
2.0% |
| Pain |
2.0% |
| Psoas Abscess |
2.0% |
| Sepsis |
2.0% |
| Anxiety |
1.3% |
| Back Pain |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Coronary Artery Disease |
1.3% |
| Diabetic Neuropathy |
1.3% |
| Nausea |
1.3% |
| Psoriasis |
1.3% |
| Blood Cholesterol |
0.7% |
| Blood Pressure |
0.7% |
| Breast Cancer |
0.7% |
|
| Toxic Encephalopathy |
12.5% |
| Polymyalgia Rheumatica |
8.3% |
| Renal Failure |
8.3% |
| Acute Respiratory Distress Syndrome |
4.2% |
| Adverse Reaction |
4.2% |
| Angioedema |
4.2% |
| Bile Duct Cancer |
4.2% |
| Blood Glucose Increased |
4.2% |
| Blood Pressure Fluctuation |
4.2% |
| Cerebrovascular Accident |
4.2% |
| Circulatory Collapse |
4.2% |
| Completed Suicide |
4.2% |
| Death |
4.2% |
| Diarrhoea |
4.2% |
| Diverticulitis |
4.2% |
| Dizziness |
4.2% |
| Drug Ineffective |
4.2% |
| Fluid Overload |
4.2% |
| Glycosylated Haemoglobin Increased |
4.2% |
| Haematemesis |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.8% |
| Diabetes Mellitus |
10.1% |
| Hypertension |
7.7% |
| Rheumatoid Arthritis |
5.7% |
| Psoriasis |
4.3% |
| Type 2 Diabetes Mellitus |
3.5% |
| Blood Cholesterol Increased |
3.1% |
| Pain |
2.8% |
| Psoriatic Arthropathy |
2.1% |
| Multiple Myeloma |
1.8% |
| Vitamin Supplementation |
1.5% |
| Depression |
1.5% |
| Crohn's Disease |
1.4% |
| Prophylaxis |
1.0% |
| Anxiety |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Blood Pressure |
0.8% |
| Cardiac Disorder |
0.8% |
| Mineral Supplementation |
0.7% |
| Atrial Fibrillation |
0.7% |
|
| Injection Site Pain |
17.2% |
| Psoriasis |
7.4% |
| Pruritus |
6.1% |
| Drug Dose Omission |
5.5% |
| Drug Ineffective |
5.5% |
| Bladder Cancer |
4.9% |
| Pneumonia |
4.9% |
| Arthralgia |
4.3% |
| Diarrhoea |
4.3% |
| Fatigue |
4.3% |
| Renal Failure Acute |
4.3% |
| Blood Glucose Increased |
3.7% |
| Cough |
3.7% |
| Injection Site Haemorrhage |
3.7% |
| Injection Site Swelling |
3.7% |
| Nasopharyngitis |
3.7% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Deep Vein Thrombosis |
3.1% |
| Injection Site Haematoma |
3.1% |
| Pain |
3.1% |
|
| Interacting |
| Blood Pressure Abnormal |
28.6% |
| Product Used For Unknown Indication |
28.6% |
| Blood Cholesterol Increased |
14.3% |
| Diabetes Mellitus |
14.3% |
| Mineral Supplementation |
14.3% |
|
|
